购物车
- 全部删除
- 您的购物车当前为空
RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively).
RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,620 | 35日内发货 | |
5 mg | ¥ 5,880 | 35日内发货 | |
10 mg | ¥ 9,870 | 35日内发货 |
产品描述 | RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively). |
靶点活性 | NPFF2R (human):75±9 nM(ki), NPFF1R (human):(ki)58±5 nM |
体内活性 | RF9 (10 μg) infused alone does not result in a significant alteration of MAP or heart rate. When NPFF is applied in conjunction with RF9, MAP, and heart rate increases evoked by NPFF are significantly blocked. It is worthy to note that RF9 (30 nmol) significantly reduces the hypothermia induced by morphine (5 nmol) [1][2]. |
分子量 | 482.62 |
分子式 | C26H38N6O3 |
CAS No. | 876310-60-0 |
密度 | 1.42 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 150 mg/mL (310.80 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容